Ottacef-T for Advanced Infection Control

Ottacef-T is a potent combination antibiotic injection containing 1000 mg of Ceftriaxone and 125 mg of Tazobactam. It is designed to treat a wide range of moderate to severe bacterial infections, especially those caused by resistant organisms.

How Ceftriaxone + Tazobactam Works

Ceftriaxone works by inhibiting bacterial cell wall synthesis, leading to bacterial death. However, certain bacteria produce enzymes called beta-lactamases that can inactivate antibiotics. Tazobactam acts as a beta-lactamase inhibitor, protecting Ceftriaxone from degradation and enhancing its antibacterial effectiveness against resistant strains.

Key Benefits of Ottacef-T

Ottacef-T offers broad-spectrum coverage and is effective in treating infections of the respiratory tract, urinary tract, abdomen, skin, and bloodstream. The combination ensures faster bacterial clearance, improved treatment outcomes, and reduced risk of antibiotic resistance. It is widely used in hospitals and critical care settings.

Usage of Ceftriaxone + Tazobactam

This injection is administered intravenously (IV) or intramuscularly (IM) under the supervision of a healthcare professional. The dosage and duration depend on the severity of the infection and the patient’s condition. Completing the full prescribed course is essential for effective treatment.

Ottacef-T Ceftriaxone 1000 mg + Tazobactam 125 mg Injection is a reliable and advanced solution for managing serious bacterial infections. Its dual-action mechanism enhances efficacy and helps combat resistant bacteria, making it a preferred choice in modern clinical practice.